{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:01:22Z","timestamp":1782831682860,"version":"3.54.5"},"reference-count":34,"publisher":"XMLink","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["icjournal.org"],"crossmark-restriction":false},"short-container-title":["Infect Chemother"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3947\/ic.2021.0034","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T04:30:18Z","timestamp":1627965018000},"page":"503","update-policy":"https:\/\/doi.org\/10.3947\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection"],"prefix":"10.3947","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-957X","authenticated-orcid":false,"given":"Wichai","family":"Santimaleeworagun","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand."},{"name":"Antibiotic Optimization and Patient Care Project by Pharmaceutical Initiative for Resistant Bacteria and Infectious Diseases Working Group [PIRBIG], Nakhon Pathom, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7939-6834","authenticated-orcid":false,"given":"Dhitiwat","family":"Changpradub","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5265-5808","authenticated-orcid":false,"given":"Jatapat","family":"Hemapanpairoa","sequence":"additional","affiliation":[{"name":"Antibiotic Optimization and Patient Care Project by Pharmaceutical Initiative for Resistant Bacteria and Infectious Diseases Working Group [PIRBIG], Nakhon Pathom, Thailand."},{"name":"Department of Pharmacy Practice and Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-3861","authenticated-orcid":false,"given":"Sudaluck","family":"Thunyaharn","sequence":"additional","affiliation":[{"name":"Faculty of Medical Technology, Nakhonratchasima College, Nakhon Ratchasima, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","reference":[{"key":"10.3947\/ic.2021.0034_ref1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.idc.2016.07.009","volume":"30","author":"Reyes","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.3947\/ic.2021.0034_ref2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/mdr.2017.0147","volume":"24","author":"Ahmed","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.3947\/ic.2021.0034_ref3","unstructured":"World Health Organization (WHO). WHO publishes list of bacteria for which new antibiotics are urgently needed. Cited 27 Febuary 27 2017. Available at: http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/bacteria-antibiotics-needed\/en\/"},{"key":"10.3947\/ic.2021.0034_ref4","unstructured":"National Antimicrobial Resistant Surveillance Center. Thailand. Antibiogram 2018. Cited 20 Febrary 2019. Available at: http:\/\/narst.dmsc.moph.go.th\/"},{"key":"10.3947\/ic.2021.0034_ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3201\/eid0702.010205","volume":"7","author":"Rice","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.3947\/ic.2021.0034_ref6","first-page":"217","volume":"8","author":"O'Driscoll","year":"2015","journal-title":"Infect Drug Resist"},{"key":"10.3947\/ic.2021.0034_ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.3947\/ic.2021.0034_ref8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2147\/IDR.S208298","volume":"12","author":"Hemapanpairoa","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.3947\/ic.2021.0034_ref9","first-page":"87","volume":"5","author":"Ager","year":"2012","journal-title":"Infect Drug Resist"},{"key":"10.3947\/ic.2021.0034_ref10","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/jac\/dkt541","volume":"69","author":"Mendes","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.3947\/ic.2021.0034_ref11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(00)02173-5","volume":"355","author":"Senior","year":"2000","journal-title":"Lancet"},{"key":"10.3947\/ic.2021.0034_ref12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijid.2014.01.016","volume":"22","author":"Dong","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.3947\/ic.2021.0034_ref13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/cid\/cis210","volume":"54","author":"Theuretzbacher","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.3947\/ic.2021.0034_ref14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003088-200342150-00007","volume":"42","author":"Rayner","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.3947\/ic.2021.0034_ref15","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/jac\/dks201","volume":"67","author":"Tsuji","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.3947\/ic.2021.0034_ref16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijantimicag.2013.02.020","volume":"41","author":"Cattaneo","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.3947\/ic.2021.0034_ref17","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","volume":"67","author":"Pea","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.3947\/ic.2021.0034_ref18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3947\/ic.2020.52.3.345","volume":"52","author":"Santimaleeworagun","year":"2020","journal-title":"Infect Chemother"},{"key":"10.3947\/ic.2021.0034_ref19","unstructured":"Centers for Disease Control and Prevention (CDC). National Healthcare Safety Network (NHSN) patient safety component manual: Identifying Healthcare-associated Infections (HAI) for NHSN surveillance. Cited 20 Febuary 2019. Available at: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf"},{"key":"10.3947\/ic.2021.0034_ref20","first-page":"282","volume-title":"Performance standards for antimicrobial susceptibility testing: Twenty-ninth informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2019"},{"key":"10.3947\/ic.2021.0034_ref21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.47.2.548-553.2003","volume":"47","author":"Meagher","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3947\/ic.2021.0034_ref22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijid.2020.02.044","volume":"93","author":"Barrasa","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.3947\/ic.2021.0034_ref23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00002018-200831090-00004","volume":"31","author":"Falagas","year":"2008","journal-title":"Drug Saf"},{"key":"10.3947\/ic.2021.0034_ref24","first-page":"2049936119828964","volume":"6","author":"Narayanan","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"10.3947\/ic.2021.0034_ref25","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/AAC.00390-15","volume":"59","author":"Chen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3947\/ic.2021.0034_ref26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jgar.2017.06.002","volume":"10","author":"Houri","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.3947\/ic.2021.0034_ref27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","volume":"40","author":"Bender","year":"2018","journal-title":"Drug Resist Updat"},{"key":"10.3947\/ic.2021.0034_ref28","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/jac\/dkx149","volume":"72","author":"Taubert","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.3947\/ic.2021.0034_ref29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijantimicag.2007.09.009","volume":"31","author":"Adembri","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.3947\/ic.2021.0034_ref30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jcpt.12762","volume":"44","author":"Kim","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.3947\/ic.2021.0034_ref31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01194-06","volume":"51","author":"Boak","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3947\/ic.2021.0034_ref32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2016.06.010","volume":"48","author":"Zhao","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.3947\/ic.2021.0034_ref33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/14656566.2018.1479397","volume":"19","author":"Mercuro","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.3947\/ic.2021.0034_ref34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/jcpt.13359","volume":"46","author":"Dai","year":"2021","journal-title":"J Clin Pharm Ther"}],"container-title":["Infection & Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/icjournal.org\/pdf\/10.3947\/ic.2021.0034","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2021.0034","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2021.0034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:16:13Z","timestamp":1633047373000},"score":1,"resource":{"primary":{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2021.0034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3947\/ic.2021.0034","relation":{},"ISSN":["2093-2340","2092-6448"],"issn-type":[{"value":"2093-2340","type":"print"},{"value":"2092-6448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"2021-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-28","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"Copyright \u00a9 2021 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}